Playback speed
10 seconds
ASCO® GI 2024 Insights: "EMERALD-1 Trial - The Combination Therapy of Durvalumab + Bevacizumab, With TACE, for Unresectable HCC"
By
ecancer
FEATURING
Riccardo Lencioni
By
ecancer
FEATURING
Riccardo Lencioni
95 views
February 12, 2024
Login to view comments.
Click here to Login